Vitamin D status and the effects of oral vitamin D treatment in children with vitiligo: A prospective study.
Clin Nutr ESPEN. 2016 Oct;15:28-31. doi: 10.1016/j.clnesp.2016.05.006. Epub 2016 Jun 9.
Karagüzel G1, Sakarya NP2, Bahadır S3, Yaman S4, Ökten A5.
All 30 patients (aged 6-17 years) got topical tacrolimus for 6 months
14 patients got maintenance dose of Vitamin D (1500 IU if 10-20 ng, 3000 IU if < 10 ng)
Apparently the other 16 patients had vitamin D levels > 20 ng
Area of poor skin color (cm2)
With Vitamin D | No Vitamin D | |
Initial | 66 cm2 | 35 cm2 |
After 6 months | 48 cm2 | 54 cm2 |
% change of lesion | 25% reduction | 54% increase |
VitaminDWiki
- Vitamin D might have provided even better results if used topically
- Wonder if tacrolimus provided any benefit
- Search VitaminDWiki for vitiligo 312 items as of Sept 2019
- Skin whitening cream (RD) may cause blotchy skin, 5,000 Vitamin D can treat it – RCT Feb 2018
- Video by Dr. Coimbra – 95 percent of auto-immune cured with vitamin D in high doses - April 2014
- 35,000 IU vitamin D daily for 6 months helped ALL psoriasis suffers (106 ng) – Brazil March 2013
- Vitiligo (loss of skin pigment) treated by narrowband UVB
Two out of 16 vitiligo patients showed no repigmentation of the affected areas;
four patients showed 1–25% repigmentation,
five patients showed 26–50% repigmentation,
five patients showed 51–75% repigmentation and
none showed more than 75% repigmentation of the affected areas
Vitiligo and Vitamin D Receptor
- Vitiligo (spotty skin coloring) is 4 X more likely if poor Vitamin D Receptor – meta-analysis July 2018
- Vitamin D Receptor in vitiligo skin activated by UVB – May 2018
The risk of 41 diseases at least double with poor Vitamin D Receptor as of July 2019
Items in both categories Autoimmune and Vitamin D Receptor are listed here:
- An activated Vitamin D Receptor fights Autoimmune Diseases, Infections, Cancers, etc. – Dec 2023
- Vitamin D and it’s related genes regulate the immune system – Aug 2023
- Graves' disease 2X more likely if poor Vitamin D Receptor (like many other autoimmune diseases) – May 2021
- Autoimmune disease treated by Vitamin D, Zinc (and other activators of Vitamin D Receptor) – Oct 2019
- Vitamin D Receptor is associated in over 58 autoimmune studies
- Temporary hair loss (Telogen Effluvium) is 15X more likely if poor Vitamin D Receptor – Oct 2019
- Autoimmunity problems often associated with poor Vitamin D Receptors – March 2019
- Many autoimmune diseases associated with low vitamin D or poor Vit D genes – July 2019
- Adaptive and innate immune system, vitamin D genes, and Rheumatoid Arthritis – June 2019
- Resveratrol Role in Autoimmune Disease-A Mini-Review. – Dec 2016
- Immunological effects of vitamin D and their relations to autoimmunity – March 2019
- Resveratrol improves health (Vitamin D receptor, etc.) - many studies
- Vitiligo (spotty skin coloring) is 4 X more likely if poor Vitamin D Receptor – meta-analysis July 2018
- Vitamin D Receptor and autoimmune diseases – Jan 2017
- Inflammation and immune responses to Vitamin D (perhaps need to measure active vitamin D) – July 2017
- Familial Mediterranean Fever is 3X more likely if poor Vitamin D Receptors (males) – Sept 2017
- Many autoimmune diseases associated with latitude and vitamin D receptor – March 2016
- Vitamin D Receptor role in Autoimmune Diseases and or cancers – Nov 2013
- Endometriosis treated, and perhaps prevented, by vitamin D - many studies
Items in both categories Autoimmune and Skin are listed here:
- Half as much blistering diseases (bullous) in portions of Chile with lots of sunshine – Feb 2025
- Vitiligo (spotty skin coloring) is 4 X more likely if poor Vitamin D Receptor – meta-analysis July 2018
- Spotty skin coloring (vitiligo) treated by augmenting topical tacrolimus with oral Vitamin D – Oct 2016
- Rare skin diseases (autoimmune bullous ) strongly associated with low vitamin D and is increasing – Feb 2015
- Low Vitamin D strongly associated with Systemic Sclerosis - many studies
See also web
- https://en.wikipedia.org/wiki/Tacrolimus
- Use of Tacrolimus Ointment in Vitiligo Alone or in Combination Therapy 2009
"Current treatments for vitiligo are largely unsatisfactory. Topical corticosteroids and phototherapy (narrow-band UVB and psoralen+UVA) are the most prescribed, however, these therapies are often not effective and have important side-effect, especially when used for a long time. Many studies have reported the efficacy and safety of tacrolimus ointment in adults and children with vitiligo, particularly when located on the head and neck. Successful treatment is possible when it is combined with other therapies, such as narrow-band UVB, microphototherapy, helium-neon laser, or narrow-band excimer laser." - How I help people understand vitiligo TedTalk Video NYC TV News anchor
Learned how to react positivily. Is now is a spokesman for the problem https://leethomas.com/
BACKGROUND & AIMS:
Vitiligo is a pigmentary disorder and autoimmune pathogenesis seems most likely. Decreased vitamin D levels have been related to several autoimmune diseases. Little is known about the association of vitiligo and vitamin D. We aimed to evaluate serum 25-hydroxyvitamin D [25(OH)D] levels in children with vitiligo and to determine the efficacy of oral vitamin D therapy on the repigmentation of vitamin D deficient patients.
METHODS:
Thirty patients aged 6-17 years with vitiligo and 30 sex- and age-matched apparently healthy controls were included in this prospective study. Size of the vitiligo representative area was estimated using the point counting method and blood samples were obtained at the beginning and month six. By the end of the study, all patients treated with topical tacrolimus for six months and the patients who were vitamin D deficient (n = 14) had been on combination treatment of oral vitamin D and topical tacrolimus. A dose of 1500 IU/day vitamin D was given if the serum 25(OH)D levels <20 ng/ml and 3000 IU/day was given if the levels <10 ng/ml for six months. Serum 25(OH)D levels were measured by high-performance liquid chromatography.
RESULTS:
Serum 25(OH)D levels of patients and controls were not significantly different (p > 0.05). Lesion size decreased from 66.1 ± 58.3 cm2 to 48.0 ± 52.6 cm2 after six months of treatment in patients who received combination treatment (p < 0.001) and increased in patients who received only topical therapy from 34.8 ± 48.1 cm2 to 53.5 ± 64.9 cm2 (p < 0.01).
CONCLUSIONS:
Although we did not determine decreased serum 25(OH)D levels in children with vitiligo, we showed that combination treatment with oral vitamin D and topical tacrolimus is more effective in reaching repigmentation than topical tacrolimus alone. Oral vitamin D supplementation might be useful for children with vitiligo who are also deficient in vitamin D.
PMID: 28531780 DOI: 10.1016/j.clnesp.2016.05.006